Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Childhood-onset Epileptic Encephalopathies
NCT03779672Phase 4Completed
- Start
- Feb 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in epileptic encephalopathy. Started Feb 2019; status: completed.
02
Drugs
memantine
03
Conditions
epileptic encephalopathy
Beyond the preview
Go deeper on NCT03779672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779672.